ClinConnect ClinConnect Logo
Search / Trial NCT06442579

The Influence of Cortical Lateralization on Selective Motor Control of the Arm Swing During Independent Walking After Stroke.

Launched by UNIVERSITY HOSPITAL, GHENT · May 29, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Emg Eeg Gait Arm Swing Kinematics

ClinConnect Summary

This clinical trial is studying how the brain controls arm movement while walking, especially in people who have had a stroke. Researchers want to understand the relationship between brain activity and arm swing in individuals who can walk independently after a stroke. They will compare how the brains of stroke survivors and healthy individuals respond during walking and look for ways to help improve arm movement, which is important for better walking after a stroke.

To be eligible for this study, participants who have had a stroke must have experienced their first stroke within the last year, be able to walk for at least 10 minutes, and have some weakness in their arm. Healthy participants must be at least 18 years old and also able to walk for 10 minutes. Throughout the trial, participants can expect to undergo tests that measure their muscle control and brain activity while walking. This research could lead to new treatments that help improve walking and arm movement for those recovering from a stroke.

Gender

ALL

Eligibility criteria

  • Stroke
  • Inclusion Criteria:
  • First-ever, ischemic and cerebral stroke
  • Maximum one-year post-stroke
  • Able to walk at least 10 minutes (FAC ≥ 3)
  • Presence of upper limb paresis (NIHSS item 5a/b \> 0)
  • Exclusion Criteria:
  • Other neurological disorders
  • Healthy controls
  • Inclusion criteria:
  • Older than 18 years
  • Able to walk at least 10 minutes
  • Exlusion criteria:
  • Pregnancy

About University Hospital, Ghent

University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.

Locations

Ghent, East Flanders, Belgium

Ghent, Oost Vlaanderen, Belgium

Patients applied

0 patients applied

Trial Officials

Anke Van Bladel, PhD

Principal Investigator

Ghent University and Ghent University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported